Real-world evidence of first-line pembrolizumab plus chemotherapy in metastatic non-squamous NSCLC: A single-centre experience

被引：0
|
作者：
Bose, Subhadeep [1 ]
Khaja, Mujtaba Syed [1 ]
Siva, Asha [1 ]
Wilson, Paula [1 ]
Grist, Helen [1 ]
Murukesh, Nishanth [1 ]
机构：
[1] Worcestershire Acute Hosp NHS Trust, Worcester, W Midlands, England
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2023年 / 41卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e21091
引用
收藏
页数：1
相关论文
共 50 条
  • [1] PEMBROLIZUMAB PLUS CHEMOTHERAPY FOR FIRST-LINE TREATMENT OF METASTATIC NON-SQUAMOUS NSCLC - A NETWORK META-ANALYSIS
    Frederickson, A. M.
    Arndorfer, S.
    Lorenzi, M.
    Insinga, R.
    Chandwani, S.
    Burke, T.
    VALUE IN HEALTH, 2018, 21 : S20 - S20
  • [2] First-Line Pembrolizumab Plus Chemotherapy for Advanced Squamous NSCLC: Real-World Outcomes at U.S. Oncology Practices
    Liu, Stephen V.
    Rai, Pragya
    Wang, Dong
    Hu, Xiaohan
    Schwarzenberger, Paul Otto
    JTO CLINICAL AND RESEARCH REPORTS, 2023, 4 (02):
  • [3] The Cost-Effectiveness of Sugemalimab Plus Chemotherapy as First-Line Treatment for Metastatic Squamous and Non-squamous NSCLC in China
    Rihua Cheng
    Zhen Zhou
    Qiao Liu
    Advances in Therapy, 2023, 40 : 4298 - 4309
  • [4] The Cost-Effectiveness of Sugemalimab Plus Chemotherapy as First-Line Treatment for Metastatic Squamous and Non-squamous NSCLC in China
    Cheng, Rihua
    Zhou, Zhen
    Liu, Qiao
    ADVANCES IN THERAPY, 2023, 40 (10) : 4298 - 4309
  • [5] Pembrolizumab plus chemotherapy versus atezolizumab plus chemotherapy plus /-bevacizumab for the first-line treatment of non-squamous NSCLC: A matching-adjusted indirect comparison
    Halmos, Balazs
    Burke, Thomas
    Kalyvas, Chrysostomos
    Vandormael, Kristel
    Frederickson, Andrew
    Piperdi, Bilal
    LUNG CANCER, 2021, 155 : 175 - 182
  • [6] Real-world outcomes of Italian patients with advanced non-squamous lung cancer treated with first-line pembrolizumab plus platinum-pemetrexed
    Leonetti, Alessandro
    Perrone, Fabiana
    Puntoni, Matteo
    Maglietta, Giuseppe
    Bordi, Paola
    Bria, Emilio
    Vita, Emanuele
    Gelsomino, Francesco
    De Giglio, Andrea
    Gelibter, Alain
    Siringo, Marco
    Mazzoni, Francesca
    Caliman, Enrico
    Genova, Carlo
    Bertolini, Federica
    Guaitoli, Giorgia
    Passiglia, Francesco
    Delcuratolo, Marco Donatello
    Montrone, Michele
    Cerea, Giulio
    Pasello, Giulia
    Roca, Elisa
    Belluomini, Lorenzo
    Cecere, Fabiana Letizia
    Guida, Annalisa
    Manzo, Anna
    Adamo, Vincenzo
    Rastelli, Francesca
    Bulotta, Alessandra
    Citarella, Fabrizio
    Toschi, Luca
    Zoratto, Federica
    Cortinovis, Diego Luigi
    Berardi, Rossana
    Follador, Alessandro
    Carta, Annamaria
    Camerini, Andrea
    Salerno, Flavio
    Silva, Rosa Rita
    Baldini, Editta
    Cortellini, Alessio
    Brighenti, Matteo
    Santoni, Matteo
    Malorgio, Francesco
    Caminiti, Caterina
    Tiseo, Marcello
    EUROPEAN JOURNAL OF CANCER, 2024, 202
  • [7] Economic evaluation of sintilimab plus chemotherapy vs. pembrolizumab plus chemotherapy for the treatment of first-line advanced or metastatic squamous NSCLC
    Chen, Pingyu
    Wang, Xintian
    Zhu, Shengwen
    Li, Hongchao
    Rui, Mingjun
    Wang, Yingcheng
    Sun, Haikui
    Ma, Aixia
    FRONTIERS IN PUBLIC HEALTH, 2022, 10
  • [8] Real-world outcomes of first-line pembrolizumab plus pemetrexed-carboplatin for metastatic nonsquamous NSCLC at US oncology practices
    Velcheti, Vamsidhar
    Hu, Xiaohan
    Piperdi, Bilal
    Burke, Thomas
    SCIENTIFIC REPORTS, 2021, 11 (01)
  • [9] Real-world outcomes of first-line pembrolizumab plus pemetrexed-carboplatin for metastatic nonsquamous NSCLC at US oncology practices
    Vamsidhar Velcheti
    Xiaohan Hu
    Bilal Piperdi
    Thomas Burke
    Scientific Reports, 11
  • [10] A Phase II Trial of Pictilisib with Chemotherapy in First-Line Non-Squamous NSCLC
    Besse, Benjamin
    Luft, Alexander V.
    Fadeeva, Natalia
    Mezger, Joerg
    Beck, Thaddeus
    Bidoli, Paolo
    Denis, Fabrice
    Paschold, Eugene
    Robinet, Giles
    Groen, Harry
    Von Pawel, Joachim
    Lackner, Mark
    Gendreau, Steve
    Spoerke, Jill
    Bassett, Katia
    Koeppen, Hartmut
    Gilbert, Houston
    Jin, Huan
    Shankar, Geetha
    Lin, Wei
    Felip, Enriqueta
    JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (09) : S375 - S375
12345